Wei‐Xing Guo

Papers

Total Citations

H-Index

About

Wei-Xing Guo is a leading hepatobiliary surgeon whose research focuses on advancing surgical treatments for hepatocellular carcinoma (HCC), particularly through minimally invasive techniques. His major contributions center on evaluating the safety and efficacy of robotic hepatectomy (RH) compared to traditional open hepatectomy (OH) for complex patient populations. In his highly cited 2023 multicenter study, Guo demonstrated that RH offers significant short-term benefits—including reduced blood loss, shorter hospital stays, and lower complication rates—without compromising long-term oncologic outcomes for patients with large HCC tumors. This work has garnered 20 citations, reflecting its immediate impact on clinical practice and surgical decision-making. Guo’s research is notable for addressing a critical gap: whether robotic approaches can be safely extended to patients with challenging tumor characteristics. His findings provide robust evidence supporting the broader adoption of robotic surgery in hepatobiliary oncology, helping to shape guidelines and improve recovery for patients worldwide. Through rigorous comparative studies, Guo continues to push the boundaries of surgical innovation, making him a key figure in the evolution of liver cancer treatment.